Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone Implant for Alcohol Use Disorder
NCT07433413Phase 3Not yet recruiting
- Sponsor
- Shenzhen Sciencare Medical Industries Co., Ltd.
- Start
- Mar 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of naltrexone in alcohol use disorder (AUD), sponsored by Shenzhen Sciencare Medical Industries Co., Ltd.. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07433413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07433413.